ADCT 8-K 2026-01-08

ADC Therapeutics SA (ADCT) 8-K dated 2026-01-08 — accession 0001628280-26-001386. This URL is the filing, not the ADCT hub.

ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.

ADC Therapeutics SA filed a 8-K on 2026-01-08. Accession 0001628280-26-001386.

Cached items: 2.02, 7.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ADCT revenue for 2025-12-31 was $81.4M. Net income was -$142.6M. Revenue was up 14.9% from 2024-12-31 to 2025-12-31. ADCT currently screens at market cap $141.2M.

Not investment advice. The ADCT SEC hub lists recent forms. The stock page is the research view.